Literature DB >> 2751278

Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.

D Raoult1, M R Yeaman, O G Baca.   

Abstract

The relative lack of efficacy of the antibiotic treatment of chronic Q fever endocarditis justifies the further evaluation of the susceptibility of Coxiella burnetii to the modern quinolone antibiotics. We evaluated the efficacies of pefloxacin and ofloxacin in controlling the Nine Mile isolate of C. burnetii by using an embryonated egg assay and persistently infected L929 cells in culture. Pefloxacin was effective in controlling the intracellular parasite at a concentration of 50 micrograms per egg and 1 microgram/ml in cultures of infected cells. Ofloxacin was effective at a concentration of 25 micrograms per egg and 0.5 microgram/ml in infected-cell cultures. In light of the fact that the concentrations of antibiotics used fall within physiological ranges used in humans, ofloxacin and pefloxacin may be useful in the clinical management of chronic Q fever, for which, to date, results have been poor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751278      PMCID: PMC172502          DOI: 10.1128/AAC.33.5.621

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES.

Authors:  D F GIMENEZ
Journal:  Stain Technol       Date:  1964-05

2.  The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos.

Authors:  R A ORMSBEE; H PARKER; E G PICKENS
Journal:  J Infect Dis       Date:  1955 Mar-Apr       Impact factor: 5.226

3.  Q fever endocarditis in the south of France.

Authors:  D Raoult; J Etienne; P Massip; S Iaocono; M A Prince; P Beaurain; S Benichou; J C Auvergnat; P Mathieu; P Bachet
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

4.  Method for counting Rickettsiae and Chlamydiae in purified suspensions.

Authors:  R Silberman; P Fiset
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

5.  Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components.

Authors:  J C Williams; M G Peacock; T F McCaul
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.

Authors:  O G Baca; E T Akporiaye; A S Aragon; I L Martinez; M V Robles; N L Warner
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

7.  Q fever endocarditis.

Authors:  M J Tobin; N Cahill; G Gearty; B Maurer; S Blake; K Daly; R Hone
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

8.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

9.  Chronic Q fever endocarditis.

Authors:  M P Varma; A A Adgey; J H Connolly
Journal:  Br Heart J       Date:  1980-06

10.  Q fever endocarditis.

Authors:  M A Pierce; M S Saag; W E Dismukes; C G Cobbs
Journal:  Am J Med Sci       Date:  1986-08       Impact factor: 2.378

View more
  14 in total

1.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.

Authors:  D Raoult; H Torres; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 3.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 4.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

5.  Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells.

Authors:  D Raoult; M Drancourt; G Vestris
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 6.  Treatment of Q fever.

Authors:  D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 7.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

8.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 9.  Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

10.  In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin.

Authors:  D Raoult; P Bres; M Drancourt; G Vestris
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.